In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lpath Inc.

www.lpath.com

Latest From Lpath Inc.

Smaller But Eye-Catching Medtech Deals

Not all of the key medtech deals of 2016 were blockbusters. Herein are some of the more interesting smaller deals of the year.

Medical Device

Deals Shaping the Medical Industry, October 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in September 2016.

Deals BioPharmaceutical

LPath Merger Will Take Apollo Endosurgery Public

Obesity device firm Apollo Endosurgery and drug firm LPath Inc. have announced plans to merge in an agreement that is intended to transition the privately held Apollo into a NASDAQ-listed company.

United States Commercial

Biogen's S1P Modulator License – A Good Deal Done Too Late?

Biogen's license for the sphingosine 1-phosphate (S1P) receptor modulator MT-1303 from Mitsubishi Tanabe for up to $544m makes a lot of sense, but with four S1P-targeting drugs approved or in late-stage development did Biogen execute a good deal too late to catch up with the competition?

Gastrointestinal Neurology
See All

Company Information

  • Industry
  • Biotechnology
    • Drug Discovery Tools
    • Large Molecule
      • Antibodies
  • In Vitro Diagnostics
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Infectious & Viral Diseases
  • Inflammation
  • Neurology, Nervous System
  • Ophthalmic
  • Alias(es)
  • Medlyte Inc.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Lpath Inc.
  • Senior Management
  • Gary Atkinson, CEO & CFO
    Gary Woodnutt, PhD, SVP, CSO
    Leigh Hsu, PhD, VP, Corp. Dev. & Strategy
  • Contact Info
  • Lpath Inc.
    Phone: (858) 678-0800
    4025 Sorrento Valley Blvd.
    San Diego, CA 92121
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register